Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GENTEX CORPGNTX · Entity 3954 | Director | May 15, 2026 | May 15, 2026 |
| NEW RITE AID, LLCRAD · Entity 87704 | Director | February 20, 2019 | February 22, 2019 |
| Stark Novus Financial Inc.RIDE · Entity 7504 | Director | May 19, 2023 | May 22, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GENTEX CORP
Report date May 15, 2026 · Filed May 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-05-15 transaction · row 1
1 source rowRow 1 · 2026-05-15 · Sale · Disposed 5,939 · Balance 0 |
NEW RITE AID, LLC
Report date February 20, 2019 · Filed February 22, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 536,411 |
Reported balance
After 2019-02-20 transaction · row 1
1 source rowRow 1 · 2019-02-20 · Grant · Acquired 155,844 · Balance 536,411 |
Stark Novus Financial Inc.
Report date May 19, 2023 · Filed May 22, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 33,915 |
Reported balance
After 2023-05-19 transaction · row 1
1 source rowRow 1 · 2023-05-19 · Exercise / conversion · Acquired 31,915 · Balance 33,915 F1: Restricted stock units ("RSUs") convert into Class A common stock on a one-for-one basis. |
| Class A Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2023-05-19 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-05-19 · Exercise / conversion · Disposed 31,915 · Balance 0 F2: On May 19 2022, the reporting person was granted 31,915 RSUs vesting on May 19, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units ("RSUs") convert into Class A common stock on a one-for-one basis.
F2: On May 19 2022, the reporting person was granted 31,915 RSUs vesting on May 19, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2026 Filed May 15, 2026 20:36 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 5,939 | $22.98 | $136,449.71 |
DisclosureSEC source: 0001214328-26-000002 · primarydocument.xml · nonDerivative · entry 1 ANDERSON JOSEPH B JR · CIK 0001214328 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| May 16, 2025 Filed May 19, 2025 18:28 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 3,764 | $22.87 | $86,076.28 |
DisclosureSEC source: 0001562180-25-003977 · primarydocument.xml · nonDerivative · entry 2 ANDERSON JOSEPH B JR · CIK 0001214328 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,939 F2 · price: This transaction was executed in multiple trades ranging from $22.65 to $23.07. The price reported above reflects the weighted average price. Read SEC document |
| May 15, 2025 Filed May 19, 2025 18:28 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 5,939 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-003977 · primarydocument.xml · nonDerivative · entry 1 ANDERSON JOSEPH B JR · CIK 0001214328 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,703 F1 · shares: These shares vest 100% one year from grant award date. Read SEC document |
| May 20, 2024 Filed May 21, 2024 13:19 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 4,716 | $34.46 | $162,502.98 |
DisclosureSEC source: 0001562180-24-004255 · primarydocument.xml · nonDerivative · entry 1 ANDERSON JOSEPH B JR · CIK 0001214328 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,764 F1 · price: This transaction was executed in multiple trades at prices ranging from $34.36 to $34.59. The price reported above reflects the weighted average price. Read SEC document |
| May 16, 2024 Filed May 17, 2024 18:24 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 3,764 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004138 · primarydocument.xml · nonDerivative · entry 1 ANDERSON JOSEPH B JR · CIK 0001214328 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,480 F1 · shares: These shares vest 100% one year from grant award date. Read SEC document |
| July 31, 2023 Filed Aug 3, 2023 15:56 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 4,416 | $33.52 | $148,043.31 |
DisclosureSEC source: 0001562180-23-006132 · primarydocument.xml · nonDerivative · entry 1 ANDERSON JOSEPH B JR · CIK 0001214328 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,716 F1 · price: This transaction was executed in multiple trades at prices ranging from $33.52 to $33.535. The price reported above reflects the weighted average price. Read SEC document |
| May 19, 2023 Filed May 22, 2023 21:55 UTC | Stark Novus Financial Inc. RIDE · Entity 7504 | Exercise / conversionClass A Common Stock · Derivative | 31,915 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-008525 · form4-05222023_090517.xml · derivative · entry 2 ANDERSON JOSEPH B JR · CIK 0001214328 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 31,915 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On May 19 2022, the reporting person was granted 31,915 RSUs vesting on May 19, 2023. F2 · derivative.expiration_date: On May 19 2022, the reporting person was granted 31,915 RSUs vesting on May 19, 2023. Read SEC document |
| May 19, 2023 Filed May 22, 2023 21:55 UTC | Stark Novus Financial Inc. RIDE · Entity 7504 | Exercise / conversionClass A Common Stock | 31,915 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-008525 · form4-05222023_090517.xml · nonDerivative · entry 1 ANDERSON JOSEPH B JR · CIK 0001214328 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,915 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") convert into Class A common stock on a one-for-one basis. Read SEC document |
| May 18, 2023 Filed May 19, 2023 20:07 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 4,716 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-004283 · primarydocument.xml · nonDerivative · entry 1 ANDERSON JOSEPH B JR · CIK 0001214328 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,132 F1 · shares: These shares vest 100% one year from grant award date. Read SEC document |
| September 20, 2022 Filed Jan 18, 2023 21:04 UTC | Stark Novus Financial Inc. RIDE · Entity 7504 | PurchaseClass A Common Stock | 2,000 | $1.97 | $3,942.00 |
DisclosureSEC source: 0001415889-23-001055 · form4-01182023_090127.xml · nonDerivative · entry 1 ANDERSON JOSEPH B JR · CIK 0001214328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Read SEC document |
| May 19, 2022 Filed May 24, 2022 00:52 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 3,397 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004356 · primarydocument.xml · nonDerivative · entry 1 ANDERSON JOSEPH B JR · CIK 0001214328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,397 F1 · shares: These shares vest 100% one year from grant award date. Read SEC document |
| May 19, 2022 Filed May 24, 2022 20:09 UTC | Stark Novus Financial Inc. RIDE · Entity 7504 | GrantStock Options · Derivative | 31,915 | $0.00 Strike: $2.35 | $0.00 |
DisclosureSEC source: 0001415889-22-005594 · form4-05242022_010556.xml · derivative · entry 2 ANDERSON JOSEPH B JR · CIK 0001214328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,915 Underlying: Class A Common Stock · 31,915 shares Expires 2029-05-19 F2 · derivative.exercise_date: 31,915 stock options vest on May 19, 2023. Read SEC document |
| May 19, 2022 Filed May 24, 2022 20:09 UTC | Stark Novus Financial Inc. RIDE · Entity 7504 | GrantRestricted Stock Units · Derivative | 31,915 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-005594 · form4-05242022_010556.xml · derivative · entry 1 ANDERSON JOSEPH B JR · CIK 0001214328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,915 Underlying: Class A Common Stock · 31,915 shares Expires not disclosed F1 · derivative.exercise_date: 31,915 restricted stock units vest on May 19, 2023. F1 · derivative.expiration_date: 31,915 restricted stock units vest on May 19, 2023. Read SEC document |
| May 19, 2022 Filed May 26, 2022 18:04 UTC Amendment | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 4,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004418 · primarydocument.xml · nonDerivative · entry 1 ANDERSON JOSEPH B JR · CIK 0001214328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,416 F1 · shares: This Form 4 amendment is to correct an administrative error in column 4 and 5 of the Form 4 filed on May 23, 2022, which resulted in the number of restricted stock award reported as acquired by the reporting person being understated in the original filing. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 15:25 UTC | NEW RITE AID, LLC RAD · Entity 87704 | GrantCommon Stock | 155,844 | $0.77 | $119,999.88 |
DisclosureSEC source: 0001209191-19-012497 · doc4.xml · nonDerivative · entry 1 ANDERSON JOSEPH B JR · CIK 0001214328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 536,411 Read SEC document |
| July 17, 2017 Filed Jul 21, 2017 16:56 UTC | NEW RITE AID, LLC RAD · Entity 87704 | GrantCommon Stock | 51,984 | $0.00 | $0.00 |
DisclosureSEC source: 0001710635-17-000004 · primary_doc.xml · nonDerivative · entry 1 ANDERSON JOSEPH B JR · CIK 0001214328 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380,567 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.